Cargando…
A broader neutralizing antibody against all the current VOCs and VOIs targets unique epitope of SARS-CoV-2 RBD
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Nature Singapore
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385086/ https://www.ncbi.nlm.nih.gov/pubmed/35977939 http://dx.doi.org/10.1038/s41421-022-00443-w |
| _version_ | 1784769521822728192 |
|---|---|
| author | Liu, Shuo Jia, Zijing Nie, Jianhui Liang, Ziteng Xie, Jingshu Wang, Lei Zhang, Li Wang, Xiangxi Wang, Youchun Huang, Weijin |
| author_facet | Liu, Shuo Jia, Zijing Nie, Jianhui Liang, Ziteng Xie, Jingshu Wang, Lei Zhang, Li Wang, Xiangxi Wang, Youchun Huang, Weijin |
| author_sort | Liu, Shuo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9385086 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer Nature Singapore |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93850862022-08-18 A broader neutralizing antibody against all the current VOCs and VOIs targets unique epitope of SARS-CoV-2 RBD Liu, Shuo Jia, Zijing Nie, Jianhui Liang, Ziteng Xie, Jingshu Wang, Lei Zhang, Li Wang, Xiangxi Wang, Youchun Huang, Weijin Cell Discov Correspondence Springer Nature Singapore 2022-08-17 /pmc/articles/PMC9385086/ /pubmed/35977939 http://dx.doi.org/10.1038/s41421-022-00443-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Liu, Shuo Jia, Zijing Nie, Jianhui Liang, Ziteng Xie, Jingshu Wang, Lei Zhang, Li Wang, Xiangxi Wang, Youchun Huang, Weijin A broader neutralizing antibody against all the current VOCs and VOIs targets unique epitope of SARS-CoV-2 RBD |
| title | A broader neutralizing antibody against all the current VOCs and VOIs targets unique epitope of SARS-CoV-2 RBD |
| title_full | A broader neutralizing antibody against all the current VOCs and VOIs targets unique epitope of SARS-CoV-2 RBD |
| title_fullStr | A broader neutralizing antibody against all the current VOCs and VOIs targets unique epitope of SARS-CoV-2 RBD |
| title_full_unstemmed | A broader neutralizing antibody against all the current VOCs and VOIs targets unique epitope of SARS-CoV-2 RBD |
| title_short | A broader neutralizing antibody against all the current VOCs and VOIs targets unique epitope of SARS-CoV-2 RBD |
| title_sort | broader neutralizing antibody against all the current vocs and vois targets unique epitope of sars-cov-2 rbd |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385086/ https://www.ncbi.nlm.nih.gov/pubmed/35977939 http://dx.doi.org/10.1038/s41421-022-00443-w |
| work_keys_str_mv | AT liushuo abroaderneutralizingantibodyagainstallthecurrentvocsandvoistargetsuniqueepitopeofsarscov2rbd AT jiazijing abroaderneutralizingantibodyagainstallthecurrentvocsandvoistargetsuniqueepitopeofsarscov2rbd AT niejianhui abroaderneutralizingantibodyagainstallthecurrentvocsandvoistargetsuniqueepitopeofsarscov2rbd AT liangziteng abroaderneutralizingantibodyagainstallthecurrentvocsandvoistargetsuniqueepitopeofsarscov2rbd AT xiejingshu abroaderneutralizingantibodyagainstallthecurrentvocsandvoistargetsuniqueepitopeofsarscov2rbd AT wanglei abroaderneutralizingantibodyagainstallthecurrentvocsandvoistargetsuniqueepitopeofsarscov2rbd AT zhangli abroaderneutralizingantibodyagainstallthecurrentvocsandvoistargetsuniqueepitopeofsarscov2rbd AT wangxiangxi abroaderneutralizingantibodyagainstallthecurrentvocsandvoistargetsuniqueepitopeofsarscov2rbd AT wangyouchun abroaderneutralizingantibodyagainstallthecurrentvocsandvoistargetsuniqueepitopeofsarscov2rbd AT huangweijin abroaderneutralizingantibodyagainstallthecurrentvocsandvoistargetsuniqueepitopeofsarscov2rbd AT liushuo broaderneutralizingantibodyagainstallthecurrentvocsandvoistargetsuniqueepitopeofsarscov2rbd AT jiazijing broaderneutralizingantibodyagainstallthecurrentvocsandvoistargetsuniqueepitopeofsarscov2rbd AT niejianhui broaderneutralizingantibodyagainstallthecurrentvocsandvoistargetsuniqueepitopeofsarscov2rbd AT liangziteng broaderneutralizingantibodyagainstallthecurrentvocsandvoistargetsuniqueepitopeofsarscov2rbd AT xiejingshu broaderneutralizingantibodyagainstallthecurrentvocsandvoistargetsuniqueepitopeofsarscov2rbd AT wanglei broaderneutralizingantibodyagainstallthecurrentvocsandvoistargetsuniqueepitopeofsarscov2rbd AT zhangli broaderneutralizingantibodyagainstallthecurrentvocsandvoistargetsuniqueepitopeofsarscov2rbd AT wangxiangxi broaderneutralizingantibodyagainstallthecurrentvocsandvoistargetsuniqueepitopeofsarscov2rbd AT wangyouchun broaderneutralizingantibodyagainstallthecurrentvocsandvoistargetsuniqueepitopeofsarscov2rbd AT huangweijin broaderneutralizingantibodyagainstallthecurrentvocsandvoistargetsuniqueepitopeofsarscov2rbd |